테르가제 뺏긴 파마리서치, 자회사 자본잠식 가속도

The strategic shift in Tergase distribution highlights the critical importance of specialized medical sales channels over general aesthetic networks in the recombinant hyaluronidase market. While GC Wellbeing gains a high-growth asset to synergize with its injection portfolio, PharmaResearch Medicare faces a significant hurdle in stabilizing its business amid capital impairment.